Nuuron
Latest round
- Seed
Last raised
- Oct 2024
Total raised
- $3.8M
Investors
- 11
About Nuuron
Founded in 2023 and based in Berlin, Nuuron GmbH operates as a neuromodulation technology company. The company was founded by Fabian Queisner and Markus Müschenich. Nuuron develops Memory Pacemaker, which is a digital drug to treat Alzheimer's disease. The company’s therapy uses advanced VR and AR technologies to deliver ultra-high-frequency, digital-photonic stimuli to the brain through the retina. The digital drug activates the brain's memory system and improves memory formation and recall in Alzheimer's patients.
Who invested in Nuuron
11 investors across 1 round
See all investors in Nuuron
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 21, 2024
Amount
$3.8M
Investors
Questions about Nuuron
Who invested in Nuuron?
Nuuron has 11 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nuuron raised?
Nuuron has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nuuron last raise money?
Nuuron's most recent round on record is a Seed, in Oct 2024.
What does Nuuron do?
Founded in 2023 and based in Berlin, Nuuron GmbH operates as a neuromodulation technology company.
Where is Nuuron headquartered?
Nuuron is headquartered in Berlin, Germany.
Which VCs invest in companies like Nuuron?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Balderton Capital and Sofinnova Partners back software companies at Nuuron's stage. Their profiles are linked below.
VCs backing software startups at Seed
Raising like Nuuron? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.